Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gatti

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Reumatismo|September 10, 2016
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritisA Fassio, L Idolazzi, M A Jaber, et al.
British Journal of Haematology|September 30, 1998
Dendritic cells derived from bone marrow and CD34+ selected blood progenitor cells of myeloma patients, cultured in serum-free media, do not contain the Kaposi sarcoma herpesvirus genomeM Mitterer, W Mair, D Gatti, et al.
Transplantation Proceedings|September 23, 2014
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipientsP Tomei, G Zaza, S Granata, et al.
Reumatismo|November 24, 2021
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trialC Benini, G Rubino, G Paolazzi, et al.
Calcified Tissue International|January 29, 2017
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian StudyO Viapiana, L Idolazzi, A Fassio, et al.
Bone|September 1, 2004
Prevalence and correlates of vertebral fractures in adults with cystic fibrosisM Rossini, A Del Marco, F Dal Santo, et al.
Bone|July 8, 2017
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian studyL Idolazzi, A Fassio, O Viapiana, et al.
Reumatismo|July 24, 2020
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-lifeG Adami, A Giollo, M Rossini, et al.
Reumatismo|April 2, 2015
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?M Rossini, O Viapiana, G Orsolini, et al.
Bone|September 19, 2003
Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosisV Braga, D Gatti, F Colapietro, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Reumatismo|September 10, 2016
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritisA Fassio, L Idolazzi, M A Jaber, et al.
British Journal of Haematology|September 30, 1998
Dendritic cells derived from bone marrow and CD34+ selected blood progenitor cells of myeloma patients, cultured in serum-free media, do not contain the Kaposi sarcoma herpesvirus genomeM Mitterer, W Mair, D Gatti, et al.
Transplantation Proceedings|September 23, 2014
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipientsP Tomei, G Zaza, S Granata, et al.
Reumatismo|November 24, 2021
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trialC Benini, G Rubino, G Paolazzi, et al.
Calcified Tissue International|January 29, 2017
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian StudyO Viapiana, L Idolazzi, A Fassio, et al.
Bone|September 1, 2004
Prevalence and correlates of vertebral fractures in adults with cystic fibrosisM Rossini, A Del Marco, F Dal Santo, et al.
Bone|July 8, 2017
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian studyL Idolazzi, A Fassio, O Viapiana, et al.
Reumatismo|July 24, 2020
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-lifeG Adami, A Giollo, M Rossini, et al.
Reumatismo|April 2, 2015
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?M Rossini, O Viapiana, G Orsolini, et al.
Bone|September 19, 2003
Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosisV Braga, D Gatti, F Colapietro, et al.
Pageof 12